EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop

Riccardo Camilotto, Davide Malfacini, Pietro Pola, Erika Morrone, Alessia Frezza, Rahul Ramalingam, Chiara Sturaro, Salvatore Pacifico, Chiara Ruzza, Remo Guerrini, Garth Whiteside, Girolamo Calo'

Biochemical Pharmacology · 2025

DOI: 10.1016/j.bcp.2025.116972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2025. Verfasst von Riccardo Camilotto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Pharmacological Sciences, Section of Pharmacology, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Receptors, Opioid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell'Istruzione dell'Universita e della Ricerca, Università degli Studi di Ferrara, Università degli Studi di Padova.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sleep-related disorders affect a significant portion of the global population. The nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor has become a promising candidate for the development of innovative drugs to treat sleep disorders. In this study, we conducted an in-depth pharmacological characterization of sunobinop, a selective NOP receptor partial agonist already under clinical evaluation for treating multiple conditions including insomnia, using a wide range of in vitro and ex vivo methodologies. Sunobinop exhibited partial agonist activity in calcium mobilization, NOP - G protein interaction, label-free bioimpedance, and cAMP inhibition assays. Notably, it demonstrated competitive antagonism in the NOP - β-Arrestin 2 recruitment and ex vivo electrically stimulated mouse Vas Deferens, assays characterized by low amplification. The findings reported here confirm and extend the characterization of sunobinop as a tool for studying NOP receptor pharmacology providing new insights into its mode of action, relevant to its clinical evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, OpioidAnimalsNociceptin ReceptorMaleMiceHumansHEK293 CellsVas DeferensCHO CellsCricetulusDrug Partial Agonism

Stichwörter der Autor:innen

GPCRsIn vitro pharmacologyNOP receptorSleep modulationSunobinop

Substanzen

Receptors, OpioidNociceptin Receptor

Autor:innen und Institutionen

  • Department of Pharmaceutical and Pharmacological Sciences, Section of Pharmacology, University of Padova, Padova, Italy.
  • Department of Pharmaceutical and Pharmacological Sciences, Section of Pharmacology, University of Padova, Padova, Italy. Electronic address: davide.malfacini@unipd.it.
  • Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.
  • Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
  • Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy; LTTA Laboratory for Advanced Therapies, Technopole of Ferrara 44121 Ferrara, Italy.
  • Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy; LTTA Laboratory for Advanced Therapies, Technopole of Ferrara 44121 Ferrara, Italy.

Förderung

  • Ministero dell'Istruzione dell'Universita e della Ricerca
  • Università degli Studi di Ferrara
  • Università degli Studi di Padova
  • Kaiser Permanente Division of Research
  • University of Ferrara Department of Chemical and Pharmaceutical Sciences
  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Camilotto, R., Malfacini, D., Pola, P., Morrone, E., Frezza, A., Ramalingam, R., Sturaro, C., Pacifico, S., Ruzza, C., Guerrini, R., Whiteside, G., & Calo', G. (2025). In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.116972

Vancouver

Camilotto R, Malfacini D, Pola P, Morrone E, Frezza A, Ramalingam R, et al. In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop. Biochemical Pharmacology. 2025. doi:10.1016/j.bcp.2025.116972

BibTeX
@article{Camilotto2025,
  author = {Camilotto, Riccardo and Malfacini, Davide and Pola, Pietro and Morrone, Erika and Frezza, Alessia and Ramalingam, Rahul and Sturaro, Chiara and Pacifico, Salvatore and Ruzza, Chiara and Guerrini, Remo and Whiteside, Garth and Calo', Girolamo},
  title = {In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop},
  journal = {Biochemical Pharmacology},
  year = {2025},
  doi = {10.1016/j.bcp.2025.116972}
}
Kostenlos starten →